Carafate suspension indications

Indications for CARAFATE SUSPENSION: Short-term (up to 8 weeks) treatment of active duodenal ulcer. Maintenance of healed duodenal ulcers (tabs only). CARAFATE (sucralfate) Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer. Find patient medical information for Carafate Oral on WebMD including its uses, side effects and safety, How to use Carafate Suspension, (Final Dose Form).

Several studies have evaluated sucralfate as an agent to prevent NSAID-induced ulcers. In a small study of healthy males, sucralfate 1 g PO four times per day. In a multicenter, double-blind, placebo-controlled study of CARAFATE Suspension, a dosage regiment of 1 g (10 mL) four times daily was demonstrated to be superior to placebo in ulcer healing. CARAFATE (sucralfate) Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer. CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL. diabetic treatment dose during the use of sucralfate suspension might be.

Medscape - Indication-specific dosing for Carafate (sucralfate), with inappropriate intravenous administration of oral suspension; administer oral suspension. Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about Shake the oral suspension (liquid) well just before you measure a dose. Sucralfate comes in a tablet and a liquid form. The drug was approved by the Food and Drug Administration in and is manufactured by. The dose of this medicine will be different for different patients. Follow your doctor's orders For oral dosage form (suspension). To treat.